Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 10, 1999

View Archived Issues

Isis's new antisense compounds modulating human CD40 expression

Paladin to distribute Plan B morning-after pill in Canada

LifeTime receives FDA clearance to begin phase I/II trials of anticancer drug

Abbott signs licensing agreement with Wakunaga for two quinolone antibiotics

Takeda obtains North American marketing rights to Interneuron's stroke therapy

AVI and XTL collaborate on HBV and HCV treatments

Zoloft receives FDA approval for posttraumatic stress disorder

CV Therapeutics advances CVT-510 into phase II clinical trials

Aphton files IND for novel antigastrin therapy

Flamel Technologies and Novo Nordisk enter agreement for long-acting insulin

Natural metabolites of Et-743 with good antitumor activity identified by Pharma Mar

P&U initiates European registration process for oxazolidinone

Vyrex synthesizes new water-soluble propofol esters

Modulators of K(ATP) channels designed at Novo Nordisk particularly for endocrine disorders

Lilly's new serotonergic indole derivatives useful for CNS disorders

Potent and selective caspase 1 (ICE) inhibitors codeveloped at Warner-Lambert and BASF

Merck angiogenesis inhibitor is the subject of European phase II and U.S. phase I trials

Reversible inhibitors of methionine aminopeptidase-2 as antiangiogenic agents

ABX-CBL enters late-stage clinical development following promising results in GVHD patients

Dusa receives first approval of Levulan PDT for treatment of actinic keratoses

Clinical development of ISIS-2302 progresses steadily

Immune Network Research to proceed with phase II program for Alzheimer's treatment

New cardiovascular gene therapy product appears to be safe in patients

Theratechnologies' PDT strategy validated in study reported at ASH

Cantab options technology related to gene therapy of neurological disorders

Another phase II clinical trial begins with ImClone's C225 for new cancer indication

IB-367 rinse effectively reduces mucositis in BMT recipients

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...